Delisting risk
Dermata Therapeutics
Developing Bioneedle-based skincare for consumer and professional channels.
$1.34
After-hours close0.00 (0.00%)
At close$1.34(−8.22%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.55 | — | — |
| Aug 2026 | −$0.55 | −$0.74 | −34.5% |
| May 2026 | −$0.53 | −$0.48 | +9.4% |
| Mar 2026 | −$1.54 | −$1.52 | +1.3% |
| Nov 2025 | −$1.59 | −$1.65 | −3.8% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| Aug 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 18, 2026 | −$0.55 | — | — | $25.0K | — | — |
| Aug 11, 2026 | −$0.55 | −$0.74 | −34.5% | — | — | — |
| May 13, 2026 | −$0.53 | −$0.48 | +9.4% | — | — | — |
| Mar 26, 2026 | −$1.54 | −$1.52 | +1.3% | — | — | — |
| Nov 14, 2025 | −$1.59 | −$1.65 | −3.8% | — | — | — |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | ||||||
| Aug 13, 2025 | ||||||
| May 14, 2025 | ||||||
| Mar 17, 2025 | ||||||
| Nov 13, 2024 | ||||||
| Aug 7, 2024 | ||||||
| May 15, 2024 | ||||||
| Mar 21, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 10, 2023 | ||||||
| May 11, 2023 | ||||||
| Feb 21, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 15, 2022 | ||||||
| May 16, 2022 | ||||||
| Mar 28, 2022 | ||||||
| Nov 15, 2021 | ||||||
| Sep 27, 2021 | ||||||
| Aug 16, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||